GO:0004835 tubulin-tyrosine ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004835 tubulin-tyrosine ligase activity is a molecular function that catalyzes the ATP-dependent addition of L-tyrosine to detyrosinated alpha-tubulin, regenerating the tyrosinated form of the microtubule lattice.
• The reaction consumes ATP and releases ADP and phosphate, and it is reversible in principle but strongly favors tubulin tyrosination under physiological conditions.
• Tubulin-tyrosine ligase (TTL) is the founding enzyme of the TTL-like (TTLL) family, and its activity is central to the tubulin tyrosination/detyrosination cycle that marks stable versus dynamic microtubules.
• TTL competes with microtubule-destabilizing proteins such as stathmin for tubulin binding, linking tyrosination directly to microtubule dynamics.
• Dysregulated tubulin tyrosination has been implicated in cancer, immune evasion, and cardiac hypertrophy, making GO:0004835 a disease-relevant function.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the primary tools for dissecting how GO:0004835 contributes to cell and tissue phenotypes.
Description
GO:0004835, tubulin-tyrosine ligase activity, is a molecular function that catalyzes the ATP-dependent ligation of L-tyrosine to the C-terminal detyrosinated alpha-tubulin, producing tyrosinated alpha-tubulin, ADP, and phosphate. This activity defines the tyrosination arm of the tubulin tyrosination/detyrosination cycle, a post-translational modification system that generates functionally distinct microtubule populations within the cell. Because microtubules are essential for mitosis, intracellular transport, and cell shape, the enzyme that sets their tyrosination state occupies a central position in cytoskeletal regulation. The enzyme responsible for this activity, tubulin-tyrosine ligase (TTL), was first characterized biochemically in the early 1990s and has since been recognized as the prototype of a larger family of TTL-like proteins that catalyze related but distinct tubulin modifications. TTL activity is not merely a housekeeping modification; it is dynamically regulated and competes with microtubule-associated proteins for access to the tubulin C-terminus. This competition places GO:0004835 at the interface between microtubule stability and dynamics. For researchers, GO:0004835 matters because perturbations in tubulin tyrosination have been linked to human disease, including cardiac hypertrophy and cancer progression. Modern CRISPR-based models now allow direct testing of whether TTL activity is causally required for these phenotypes, making the function both a mechanistic question and a therapeutic hypothesis.
tubulin-tyrosine ligase activity At A Glance
| GO ID | GO:0004835 |
|---|---|
| GO term | tubulin-tyrosine ligase activity |
| Ontology | molecular_function |
| Synonym | alpha-tubulin:L-tyrosine ligase (ADP-forming); TTL activity; tubulinyl-tyrosine ligase activity |
| Major function | ATP-dependent ligation of L-tyrosine to detyrosinated alpha-tubulin |
| Reaction | ATP + detyrosinated alpha-tubulin + L-tyrosine = alpha-tubulin + ADP + phosphate |
| Representative enzyme | Tubulin-tyrosine ligase (TTL) |
| Related family | TTL-like (TTLL) proteins |
| Biological context | Tubulin tyrosination/detyrosination cycle and microtubule dynamics |
What Is GO:0004835?
In our own words, GO:0004835 describes the catalytic activity of an enzyme that uses ATP to attach a single L-tyrosine residue to the C-terminal end of detyrosinated alpha-tubulin. The reaction consumes one molecule of ATP and one molecule of detyrosinated alpha-tubulin plus L-tyrosine, and it releases tyrosinated alpha-tubulin, ADP, and phosphate. This activity is synonymous with alpha-tubulin:L-tyrosine ligase (ADP-forming), TTL activity, and tubulinyl-tyrosine ligase activity. It is a molecular_function term, meaning it describes what the enzyme does at the biochemical level rather than where it acts or what process it participates in.
Why Is tubulin-tyrosine ligase activity Important in Cell Biology?
GO:0004835 is important because it defines the biochemical step that regenerates tyrosinated alpha-tubulin, a modification that distinguishes dynamic microtubules from stable, detyrosinated ones. This distinction influences microtubule interactions with motors and associated proteins, and it is exploited by cells during mitosis, differentiation, and migration. Because TTL competes with stathmin for tubulin binding, the activity is directly coupled to microtubule destabilization. Clinically, altered tubulin tyrosination has been observed in cardiac hypertrophy and in cancer immune evasion, underscoring the need for precise functional models.
• Defines the tyrosination arm of the tubulin tyrosination/detyrosination cycle, a key post-translational code on microtubules.
• Regenerates tyrosinated alpha-tubulin, which marks dynamic microtubule populations.
• Competes with stathmin for tubulin binding, directly influencing microtubule stability.
• Links ATP consumption to cytoskeletal remodeling, integrating energy status with microtubule dynamics.
• Implicated in cardiac hypertrophy through TTL variants that perturb microtubule tyrosination.
• Associated with cancer immune evasion via TTLL-mediated glutamylation pathways that intersect with tubulin modification networks.
• Provides a druggable node for modulating microtubule behavior in disease.
• Serves as a model function for studying the broader TTLL enzyme family.
• Enables CRISPR-based causal testing of tubulin modification in patient-derived cells.
• Connects plant and animal microtubule biology through conserved TTL-like activities.
What Happens During tubulin-tyrosine ligase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the target protein, detyrosinated alpha-tubulin.
Tubulin-tyrosine ligase recognizes the detyrosinated C-terminus of alpha-tubulin, which exposes a glutamate residue that serves as the acceptor for tyrosine ligation. Binding is specific for the detyrosinated form, ensuring that the enzyme acts only on tubulin that has lost its terminal tyrosine. This step is competitive with other tubulin-binding proteins such as stathmin, which can occupy overlapping surfaces and thereby regulate access to the substrate.
ATP-dependent activation of tyrosine
In simple terms: ATP provides the energy to activate tyrosine so it can be attached.
The ligase uses ATP to activate L-tyrosine, forming a high-energy intermediate that facilitates transfer of the amino acid to the tubulin C-terminus. This step consumes one molecule of ATP per ligation event and releases ADP and phosphate as byproducts. The reaction is therefore energetically costly and tightly coupled to cellular ATP availability.
Ligation and product release
In simple terms: Tyrosine is stitched onto tubulin, and the finished product is released.
The activated tyrosine is covalently attached to the detyrosinated alpha-tubulin, regenerating the tyrosinated form of the protein. The enzyme then releases tyrosinated alpha-tubulin, ADP, and phosphate, completing the catalytic cycle. The newly tyrosinated tubulin can be reincorporated into microtubules, where it influences dynamics and interactions with motors and MAPs.
Coupling to the tubulin tyrosination cycle
In simple terms: The enzyme works as part of a cycle that keeps adding and removing tyrosine on tubulin.
GO:0004835 is one half of the tubulin tyrosination/detyrosination cycle; the opposing reaction is catalyzed by tubulin carboxypeptidases that remove the terminal tyrosine. The balance between these activities determines the proportion of tyrosinated versus detyrosinated microtubules, which in turn affects microtubule stability and function. This cycle is conserved and has been studied in both animal and plant systems.
Regulation by interacting proteins
In simple terms: Other proteins can block or promote the enzyme's access to tubulin.
Stathmin competes with tubulin-tyrosine ligase for tubulin binding in vitro, suggesting that the availability of free tubulin dimers regulates ligase activity. Additionally, TTLL family members are subject to regulation by kinases such as NEK5, which negatively regulates the polyglutamylase activity of TTLL4, illustrating that related enzymes are controlled by phosphorylation. Such interactions position GO:0004835 within a broader regulatory network that tunes microtubule modification states.
Key Genes Involved in GO:0004835 tubulin-tyrosine ligase activity
The following genes and proteins are directly or functionally linked to GO:0004835 tubulin-tyrosine ligase activity and its regulatory context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TTL | Catalyzes tubulin-tyrosine ligase activity (GO:0004835) | Core enzyme for tyrosination studies; target for KO and point-mutation models |
| TTLL1 | TTL-like family member with related tubulin modification activity | Comparative studies of TTLL family function |
| TTLL4 | Polyglutamylase regulated by NEK5 | Model for TTLL regulation by phosphorylation |
| TTLL12 | Rice TTL-like protein regulating phospholipase D and tubulin synthesis | Plant model for TTL-like function |
| STMN1 | Stathmin, competes with TTL for tubulin binding | Regulator of TTL access to substrate |
| NEK5 | Kinase that negatively regulates TTLL4 | Upstream regulator of TTLL family enzymes |
| GLS2 | Glutaminase 2 with moonlighting function in immune evasion | Links tubulin modification to cancer immunity |
| TTLL1 | Tubulin tyrosine ligase-like 1 involved in glutamylation | Cancer immune evasion pathway |
| YES1 | Yes1 associated transcriptional regulator, glutamylation target | Downstream effector in cancer |
| TUBA1A | Alpha-tubulin substrate for tyrosination | Direct substrate of GO:0004835 |
| TUBA1B | Alpha-tubulin isoform | Potential substrate in CRISPR models |
| TUBB | Beta-tubulin partner in dimers | Structural context for tyrosination |
| MAP1B | Microtubule-associated protein | Potential competitor or modulator |
| MAP2 | Microtubule-associated protein | Context for microtubule stability |
| KIF5B | Kinesin motor | Readout of microtubule tyrosination effects |
| DYNC1H1 | Dynein heavy chain | Readout of microtubule tyrosination effects |
| PLD | Phospholipase D regulated by TTLL12 in rice | Plant signaling link |
How Is tubulin-tyrosine ligase activity Regulated?
GO:0004835 is regulated at multiple levels. At the substrate level, the availability of detyrosinated alpha-tubulin determines ligase activity, and stathmin competes with TTL for tubulin binding, thereby limiting access to the substrate. At the enzyme level, TTLL family members are subject to post-translational regulation; for example, NEK5 negatively regulates the polyglutamylase activity of TTLL4, indicating that kinase signaling can tune related tubulin-modifying enzymes. In plants, TTLL12 regulates phospholipase D activity and tubulin synthesis, suggesting that TTL-like proteins are integrated into broader signaling networks. These layers of regulation ensure that tubulin tyrosination is responsive to cellular state and energy availability.
tubulin-tyrosine ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TTL | Cardiac hypertrophy | Patient-specific and CRISPR gene-edited iPSC-cardiomyocytes |
| TTLL1 | Pancreatic ductal adenocarcinoma immune evasion | CRISPR knockout in PDAC cell lines |
| GLS2 | Cancer metabolism and immune evasion | Overexpression and knockout models |
| STMN1 | Microtubule destabilization in cancer | Point-mutation and knockout models |
| TTLL4 | Regulation by NEK5 kinase | Knock-in and point-mutation models |
Cardiac hypertrophy
A tubulin tyrosine ligase variant has been shown to perturb microtubule tyrosination, causing hypertrophy in patient-specific and CRISPR gene-edited iPSC-cardiomyocytes. This establishes GO:0004835 as a functionally relevant node in cardiac disease and provides a human cell model for mechanistic studies.
Cancer immune evasion
The moonlighting function of glutaminase 2 promotes immune evasion of pancreatic ductal adenocarcinoma through TTLL1-mediated glutamylation of YES1 associated transcriptional regulator. Although this pathway involves glutamylation rather than tyrosination, it highlights how tubulin-modifying enzymes, including TTL-like proteins, contribute to tumor immune escape.
Microtubule-related pathologies
Because GO:0004835 controls the tyrosination state of microtubules, its dysregulation is expected to affect processes dependent on microtubule dynamics, such as mitosis and intracellular transport. The competition with stathmin further links the activity to microtubule destabilization pathways that are relevant in cancer and neurodegeneration.
From tubulin-tyrosine ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TTL required for tubulin tyrosination? | TTL knockout cell lines |
| Does a patient variant alter TTL activity? | Point-mutation knock-in iPSC-cardiomyocytes |
| Can tyrosination be restored by a tagged TTL? | Tagged knock-in of TTL |
| Does TTL overexpression alter microtubule dynamics? | Overexpression models |
| Does TTLL1 mediate immune evasion? | CRISPR knockout in PDAC cells |
| How does stathmin compete with TTL? | In vitro binding assays with purified proteins |
How to Study the tubulin-tyrosine ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ligase assay | Enzymatic activity of TTL | Confirming GO:0004835 activity and mutant effects |
| Western blot with tyrosination antibodies | Ratio of tyrosinated to detyrosinated tubulin | Cell and tissue phenotyping |
| Immunofluorescence | Spatial distribution of tyrosinated microtubules | Cytoskeleton imaging |
| Mass spectrometry | Tubulin C-terminal modification state | Proteomic profiling |
| CRISPR knockout | Loss-of-function phenotype | Causal gene testing |
| Point-mutation knock-in | Effect of specific variants | Patient variant modeling |
| Live-cell imaging | Microtubule dynamics | Real-time cytoskeleton analysis |
| Binding competition assay | Protein-protein interactions | Stathmin-TTL competition |
Biochemical ligase assays
Direct measurement of GO:0004835 activity uses purified tubulin-tyrosine ligase and detyrosinated alpha-tubulin in the presence of ATP and L-tyrosine, followed by detection of tyrosinated product. These assays are the gold standard for confirming enzyme activity and for testing mutant variants.
Proteomic and modification-specific detection
Antibodies specific for tyrosinated and detyrosinated alpha-tubulin enable western blot and immunofluorescence readouts of the tubulin tyrosination cycle. Mass spectrometry can map tubulin C-terminal modifications and quantify the balance between tyrosinated and detyrosinated forms.
CRISPR-based functional genomics
CRISPR knockout, point-mutation knock-in, and overexpression models allow causal testing of TTL and TTLL genes in disease-relevant cells. These approaches are particularly powerful when combined with patient-derived iPSCs or cancer cell lines.
Microtubule dynamics imaging
Live-cell imaging of fluorescently tagged tubulin and microtubule plus-end tracking proteins reveals how changes in GO:0004835 activity affect microtubule growth, shrinkage, and stability. Such imaging can be coupled with competition assays to study stathmin interference.
How CRISPR Can Be Used to Study GO:0004835 tubulin-tyrosine ligase activity
Knockout
CRISPR knockout of TTL or related TTLL genes eliminates GO:0004835 activity, allowing researchers to test whether tubulin tyrosination is required for specific cellular processes. Knockout models are particularly useful for validating loss-of-function phenotypes in disease-relevant cell types.
Point Mutation
Point-mutation knock-in can recreate patient-specific variants in TTL or its regulators, enabling precise dissection of how single amino acid changes alter enzyme activity and microtubule tyrosination. Such models are essential for linking genotype to molecular phenotype.
Knock-in
Tagged knock-in of TTL or TTLL genes allows endogenous labeling for imaging, immunoprecipitation, and interaction studies without overexpression artifacts. This approach preserves native regulation and is ideal for studying the tubulin tyrosination cycle in situ.
Overexpression
Overexpression of TTL or TTLL family members can amplify tubulin tyrosination or related modifications, revealing gain-of-function effects on microtubule dynamics and cell behavior. Overexpression models complement knockout studies by testing sufficiency rather than necessity.
How EDITGENE Supports tubulin-tyrosine ligase activity Research
Researchers studying tubulin-tyrosine ligase activity-related genes often need to determine whether a candidate gene is causally involved in a given phenotype, and CRISPR-based models provide the most direct route to that answer. Whether the question concerns TTL itself, TTLL family members, or downstream effectors such as stathmin, the ability to precisely edit, tag, or overexpress these genes in relevant cell types is essential for rigorous mechanistic work.
Contact EDITGENE today to design your custom CRISPR model for tubulin-tyrosine ligase activity research.
Frequently Asked Questions About tubulin-tyrosine ligase activity
What is tubulin-tyrosine ligase activity?
It is the ATP-dependent enzymatic activity that attaches L-tyrosine to detyrosinated alpha-tubulin, regenerating tyrosinated tubulin and releasing ADP and phosphate.
What is the GO ID for tubulin-tyrosine ligase activity?
The Gene Ontology ID is GO:0004835, classified under molecular_function.
What genes are involved in tubulin-tyrosine ligase activity?
The core gene is TTL, which encodes tubulin-tyrosine ligase; related TTLL family members and regulators such as STMN1 and NEK5 also participate in the broader pathway.
What reaction does GO:0004835 catalyze?
It catalyzes ATP + detyrosinated alpha-tubulin + L-tyrosine = alpha-tubulin + ADP + phosphate.
How is tubulin-tyrosine ligase activity regulated?
It is regulated by substrate availability, competition with stathmin for tubulin binding, and phosphorylation of related TTLL enzymes by kinases such as NEK5.
Is tubulin-tyrosine ligase activity linked to disease?
Yes, TTL variants have been linked to cardiac hypertrophy, and TTLL-mediated modifications contribute to cancer immune evasion.
What methods are used to study tubulin-tyrosine ligase activity?
Common methods include in vitro ligase assays, western blot with tyrosination-specific antibodies, mass spectrometry, live-cell imaging, and CRISPR-based functional models.
Can CRISPR be used to study GO:0004835?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models are widely used to test the causal role of TTL and related genes.
What is the difference between TTL and TTLL proteins?
TTL is the founding enzyme for tubulin tyrosination, while TTLL proteins are a related family that catalyze other tubulin modifications such as glutamylation and are subject to distinct regulation.
Why does tubulin tyrosination matter for microtubules?
Tyrosination marks dynamic microtubule populations and influences interactions with motors and MAPs, thereby affecting stability and function.
Conclusion
GO:0004835 tubulin-tyrosine ligase activity is a well-defined molecular function that regenerates tyrosinated alpha-tubulin through an ATP-dependent ligation reaction. Its role in the tubulin tyrosination cycle places it at the center of microtubule dynamics, with direct implications for cardiac disease and cancer. As CRISPR models become more sophisticated, the ability to precisely manipulate TTL and related genes will continue to reveal how this activity shapes cell and tissue physiology.
References
- 1. Gerlach M et al.. 2019. Tubulin Tyrosine Ligase-Mediated Modification of Proteins.. Methods Mol Biol 2012:327-355 PMID: 31161516
- 2. Jain PK et al.. 2025. Tubulin tyrosine ligase variant perturbs microtubule tyrosination, causing hypertrophy in patient-specific and CRISPR gene-edited iPSC-cardiomyocytes.. JCI Insight 10(15) PMID: 40779454
- 3. Chen X et al.. 2025. The Moonlighting Function of Glutaminase 2 Promotes Immune Evasion of Pancreatic Ductal Adenocarcinoma by Tubulin Tyrosine Ligase-like 1-Mediated Yes1 Associated Transcriptional Regulator Glutamylation.. Gastroenterology 168(6):1137-1152 PMID: 39924055
- 4. Zhang K et al.. 2022. A rice tubulin tyrosine ligase like 12 regulates phospholipase D activity and tubulin synthesis.. Plant Sci 316:111155 PMID: 35151438
- 5. Erck C et al.. 2000. Tubulin-tyrosine ligase, a long-lasting enigma.. Neurochem Res 25(1):5-10 PMID: 10685598
- 6. Melo-Hanchuk TD et al.. 2021. Polyglutamylase activity of tubulin tyrosine ligase-like 4 is negatively regulated by the never in mitosis gene A family kinase never in mitosis gene A -related kinase 5.. World J Biol Chem 12(3):38-51 PMID: 34084286
- 7. Ersfeld K et al.. 1993. Characterization of the tubulin-tyrosine ligase.. J Cell Biol 120(3):725-32 PMID: 8093886
- 8. Szyk A et al.. 2013. Tubulin tyrosine ligase and stathmin compete for tubulin binding in vitro.. J Mol Biol 425(14):2412-4 PMID: 23624152
